Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Metabolic therapy for heart disease: impact of trimetazidine.

× No keyword cloud information.

55 in total

1. Myocardial substrate metabolism influences left ventricular energetics in vivo.

Authors: C Korvald; O P Elvenes; T Myrmel
Journal: Am J Physiol Heart Circ Physiol Date: 2000-04 Impact factor: 4.733

2. Therapeutic value of a cardioprotective agent in patients with severe ischaemic cardiomyopathy.

Authors: L Brottier; J L Barat; C Combe; B Boussens; J Bonnet; H Bricaud
Journal: Eur Heart J Date: 1990-03 Impact factor: 29.983

3. Effect of nicotinic acid on myocardial metabolism in man at rest and during exercise.

Authors: B W Lassers; M L Wahlqvist; L Kaijser; L A Carlson
Journal: J Appl Physiol Date: 1972-07 Impact factor: 3.531

4. Myocardial substrate utilization during exercise in humans. Dual carbon-labeled carbohydrate isotope experiments.

Authors: E W Gertz; J A Wisneski; W C Stanley; R A Neese
Journal: J Clin Invest Date: 1988-12 Impact factor: 14.808

5. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials.

Authors: F Fath-Ordoubadi; K J Beatt
Journal: Circulation Date: 1997-08-19 Impact factor: 29.690

Review 6. New look to an old symptom: angina pectoris.

Authors: F Crea; A Gaspardone
Journal: Circulation Date: 1997-11-18 Impact factor: 29.690

7. Short- and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathy.

Authors: G Fragasso; P M Piatti Md; L Monti; A Palloshi; E Setola; P Puccetti; G Calori; G D Lopaschuk; A Margonato
Journal: Am Heart J Date: 2003-11 Impact factor: 4.749

8. Trimetazidine: a new concept in the treatment of angina. Comparison with propranolol in patients with stable angina. Trimetazidine European Multicenter Study Group.

Authors: J M Detry; P Sellier; S Pennaforte; D Cokkinos; H Dargie; P Mathes
Journal: Br J Clin Pharmacol Date: 1994-03 Impact factor: 4.335

9. The Total Ischaemic Burden European Trial (TIBET). Effects of atenolol, nifedipine SR and their combination on the exercise test and the total ischaemic burden in 608 patients with stable angina. The TIBET Study Group.

Authors: K M Fox; D Mulcahy; I Findlay; I Ford; H J Dargie
Journal: Eur Heart J Date: 1996-01 Impact factor: 29.983

10. Trimetazidine improves left ventricular function in diabetic patients with coronary artery disease: a double-blind placebo-controlled study.

Authors: Giuseppe M C Rosano; Cristiana Vitale; Barbara Sposato; Giuseppe Mercuro; Massimo Fini
Journal: Cardiovasc Diabetol Date: 2003-11-28 Impact factor: 9.951

3 in total

Review 1. Mitochondria and cardioprotection.

Authors: Fabio Di Lisa; Marcella Canton; Roberta Menabò; Nina Kaludercic; Paolo Bernardi
Journal: Heart Fail Rev Date: 2007-12 Impact factor: 4.214

2. The Role of Ivabradine and Trimetazidine in the New ESC HF Guidelines.

Authors: Ivan Milinković; Giuseppe Rosano; Yuri Lopatin; Petar M Seferović
Journal: Card Fail Rev Date: 2016-11

3. Trimetazidine therapy for diabetic mouse hearts subjected to ex vivo acute heart failure.

Authors: Emilene Breedt; Lydia Lacerda; M Faadiel Essop
Journal: PLoS One Date: 2017-06-20 Impact factor: 3.240

3 in total